Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma
- 3 May 2021
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 41 (2) , 142-150
Abstract
Histologic assessment of response to progestogen therapy is a cornerstone of nonsurgical management of atypical hyperplasia/low-grade endometrioid carcinoma. Pathologists are required to assess whether there is ongoing preneoplastic or neoplastic change in the biopsies (often multiple) taken during therapy. There have been few studies documenting the specific histologic changes induced by therapeutic progestogens and currently there are no guidelines on terminology used in this scenario. Given the need for uniformity in reporting and the lack of guidance in the current literature, we initiated an online survey (including questions, categories of reporting, and scanned slides for assessment) which was sent to all members of British Association of Gynaecological Pathologists (BAGP) and the International Society of Gynecological Pathologists (ISGyP) with the aim to assess the variability among pathologists in reporting these specimens and to come up with a consensus-based terminology for reporting of endometrial biopsies from women on progestogen therapy for endometrial atypical hyperplasia/endometrioid carcinoma. In total, 95 pathologists participated in this survey. This manuscript elaborates on the results of the survey with recommendations aimed at promoting uniform terminology in reporting these biopsies.Keywords
This publication has 34 references indexed in Scilit:
- Assessing Endometrial Hyperplasia and Carcinoma Treated With Progestin TherapyAmerican Journal of Clinical Pathology, 2012
- Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic reviewGynecologic Oncology, 2012
- Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2010
- Absolute Risk of Endometrial Carcinoma During 20-Year Follow-Up Among Women With Endometrial HyperplasiaJournal of Clinical Oncology, 2010
- The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean womenJournal of Gynecologic Oncology, 2010
- Serial histologic observation of endometrial adenocarcinoma treated with high-dose progestin until complete disappearance of carcinomatous foci-review of more than 25 biopsies from five patientsInternational Journal of Gynecological Cancer, 2008
- Morphologic Changes in the Endometrium Associated With the Use of the Mirena Coil: A Retrospective Study of 106 CasesInternational Journal of Surgical Pathology, 2007
- Reproducibility of the diagnosis of atypical endometrial hyperplasiaCancer, 2006
- Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-upGynecologic Oncology, 2004
- Hormonal Pathology of the EndometriumLaboratory Investigation, 2000